We are live on
!
Find out more
ETC
Exchange Traded Concepts Portfolio holdings
AUM
$21.9B
1-Year Est. Return
68.6%
This Fund
S&P 500
This Quarter
Est. Return
+7.82%
1 Year Est. Return
+68.6%
3 Year Est. Return
+158.93%
5 Year Est. Return
+186.62%
10 Year Est. Return
–
AUM
$478M
AUM Growth
–
Cap. Flow
+$463M
Cap. Flow
% of AUM
96.68%
Top 10 Holdings %
Top 10 Hldgs %
41.42%
Holding
487
New
487
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cardinal Health
CAH
|
+$25.7M |
| 2 |
Franklin Resources
BEN
|
+$22.4M |
| 3 |
DXC Technology
DXC
|
+$21.7M |
| 4 |
Nucor
NUE
|
+$21.5M |
| 5 |
Macy's
M
|
+$21.3M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 21.82% |
| 2 | Technology | 12.97% |
| 3 | Healthcare | 12.11% |
| 4 | Financials | 11.99% |
| 5 | Materials | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Advanced Micro Devices
AMD
$851B
| $96K | 0.02% |
+2,083
| New | +$76.7K |
|
202
NeoGenomics
NEO
$1.81B
| $96K | 0.02% |
+3,291
| New | +$78.4K |
|
203
Colgate-Palmolive
CL
$72.6B
| $95K | 0.02% |
+1,382
| New | +$94.2K |
|
204
BHP
BHP
$213B
| $94K | 0.02% |
+1,928
| New | +$87.6K |
|
205
Vertex Pharmaceuticals
VRTX
$121B
| $94K | 0.02% |
+428
| New | +$86.6K |
|
206
ServiceNow
NOW
$102B
| $93K | 0.02% |
+1,640
| New | +$86.4K |
|
207
IQVIA
IQV
$34.7B
| $90K | 0.02% |
+583
| New | +$85.1K |
|
|
CTLT
208
DELISTED
CATALENT, INC.
CTLT
| $90K | 0.02% |
+1,591
| New | +$81.1K |
|
209
Integra LifeSciences
IART
$1.54B
| $89K | 0.02% |
+1,530
| New | +$91.1K |
|
210
Penumbra
PEN
$12.5B
| $89K | 0.02% |
+544
| New | +$86.5K |
|
|
VCRA
211
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $89K | 0.02% |
+4,285
| New | +$94K |
|
212
Regeneron Pharmaceuticals
REGN
$68.8B
| $88K | 0.02% |
+234
| New | +$78.7K |
|
213
Artivion
AORT
$1.23B
| $87K | 0.02% |
+3,204
| New | +$78.7K |
|
214
Natera
NTRA
$37.5B
| $87K | 0.02% |
+2,593
| New | +$95.6K |
|
215
Glaukos
GKOS
$9.02B
| $86K | 0.02% |
+1,587
| New | +$96.6K |
|
|
B
216
Barrick Mining
B
$62.2B
| $86K | 0.02% |
+4,652
| New | +$79.9K |
|
217
Omnicell
OMCL
$1.86B
| $86K | 0.02% |
+1,051
| New | +$80.6K |
|
|
ABMD
218
DELISTED
Abiomed Inc
ABMD
| $86K | 0.02% |
+506
| New | +$93.8K |
|
219
iRhythm Holdings
IRTC
$3.59B
| $85K | 0.02% |
+1,246
| New | +$84.5K |
|
220
Myriad Genetics
MYGN
$530M
| $85K | 0.02% |
+3,123
| New | +$85.9K |
|
221
Insulet
PODD
$11.3B
| $85K | 0.02% |
+497
| New | +$82.8K |
|
222
Revvity
RVTY
$12.3B
| $85K | 0.02% |
+876
| New | +$78.2K |
|
223
Bio-Rad Laboratories Class A
BIO
$8.42B
| $84K | 0.02% |
+228
| New | +$80.4K |
|
224
QuidelOrtho
QDEL
$1.09B
| $84K | 0.02% |
+1,121
| New | +$72.4K |
|
|
NVRO
225
DELISTED
NEVRO CORP.
NVRO
| $83K | 0.02% |
+706
| New | +$69.9K |
|
Similar funds
DSA
IC
AM
BA
PAG
AA
Exchange Traded Concepts's Q4 2019 Portfolio in Review
Q4 2019 is the first quarter with a 13F filing on record for Exchange Traded Concepts, which disclosed 487 positions worth $478M. Its ten largest holdings account for 41% of the portfolio.
Its largest position is Cardinal Health: 496,944 shares worth $25.1M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 22% of assets, followed by Technology and Healthcare.
- Exchange Traded Concepts's largest Q4 2019 buy was Cardinal Health: 496,944 shares worth $25.1M.
- Exchange Traded Concepts's ten largest holdings make up 41% of its $478M portfolio in Q4 2019.
- Exchange Traded Concepts disclosed 487 positions in Q4 2019, its first 13F filing on record.
Based on Exchange Traded Concepts's 13F filing for Q4 2019, filed 22 Jan 2020.